Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07653464 · ClinicalTrials.gov registry record · Early Phase 1
Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 64
- Enrollment target
NCT07653464 is a Early Phase 1 study that has not yet begun recruiting, run by University of Missouri-Columbia. The registered enrollment target is 64 participants.
The verdict
NCT07653464, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Missouri-Columbia.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 64 participants
- Enrollment target
Study Summary
In the present study, we seek to determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.
Interventions
- DRUG human insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2026-08 |
| Est. Completion | 2032-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07653464
The ClinicalTrials.gov registry entry for NCT07653464 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which human insulin is the first listed.
NCT07653464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07653464 about?
NCT07653464 is a clinical study titled "Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity". In the present study, we seek to determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.
What is the current status of trial NCT07653464?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2026-08. Estimated completion is 2032-06.
What interventions are being tested in trial NCT07653464?
The interventions under investigation include: human insulin (DRUG).
Who is sponsoring clinical trial NCT07653464?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.